Please wait

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13D/A 0000950170-25-004293 0002049563 XXXXXXXX LIVE 1 Common Stock, par value $0.01 per share 03/27/2025 false 0001433660 477839104 JBT Marel Corp 70 West Madison Street Suite 4400 Chicago IL 60602 Eyrir Invest hf. 354 525-0200 Skolavordustigur 13 Reykjavik K6 101 Michael C. Labriola 1 (202) 973-8800 Wilson Sonsini Goodrich & Rosati, P.C. 1700 K Street NW, Fifth Floor Washington, D.C. X1 20006-3814 0002049563 N Eyrir Invest hf. b OO N K6 284948 0 284948 0 284948 N 0.5 OO Percentage ownership is based on a total of 51,880,294 shares of the Common Stock of the Issuer outstanding as of February 20, 2025, as reported by the Issuer in its Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 28, 2025. Common Stock, par value $0.01 per share JBT Marel Corp 70 West Madison Street Suite 4400 Chicago IL 60602 This Amendment No. 1 (this "Amendment") amends the statement on Schedule 13D filed by the Reporting Person with the Securities and Exchange Commission on January 10, 2025 (the "Schedule 13D"). Except as otherwise specifically provided herein, each item of the Schedule 13D remains unchanged. All capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the Schedule 13D. Item 4 of the Schedule 13D is hereby amended and supplemented as follows: On March 27, 2025, at the annual general meeting of the shareholders of the Reporting Person, the shareholders of the Reporting Person (the "Shareholders") approved a capital reduction (the "Capital Reduction") involving a pro rata in-kind distribution by the Reporting Person of an aggregate of 3,032,714 shares of the Common Stock of the Issuer to the Shareholders. On March 28, 2025, the Capital Reduction was registered with the Icelandic Register of Enterprises. The consummation of the Capital Reduction is expected to occur on or about April 3, 2025. Item 5(a) of the Schedule 13D is hereby amended and restated as follows: The information set forth in rows 11 and 13 and the "Comment for Type of Reporting Person" on the cover pages of this Amendment is incorporated by reference in its entirety into this Item 5(a). Item 5(b) of the Schedule 13D is hereby amended and restated as follows: The information set forth in rows 7 through 10 on the cover pages of this Amendment is incorporated by reference in its entirety into this Item 5(b). Item 5(c) of the Schedule 13D is hereby amended and restated as follows: On February 27, 2025, the Reporting Person sold 50,571 shares of the Common Stock of the Issuer on the open market at a weighted average price per share of $132.4862. The information set forth in Item 4 of this Amendment is hereby incorporated by reference in its entirety into this Item 5(c). Item 5(e) of the Schedule 13D is hereby amended and restated as follows: On March 27, 2025, the Reporting Person ceased to be the beneficial owner of more than five percent of the outstanding shares of the Common Stock of the Issuer. Item 6 of the Schedule 13D is hereby amended and supplemented as follows: The information set forth in Item 4 of this Amendment is hereby incorporated by reference in its entirety into this Item 6. Eyrir Invest hf. /s/ Signy Sif Sigurdardottir Signy Sif Sigurdardottir, CEO 03/28/2025